Back to Search
Start Over
Perhexiline and hypertrophic cardiomyopathy: a new horizon for metabolic modulation.
- Source :
-
Circulation [Circulation] 2010 Oct 19; Vol. 122 (16), pp. 1547-9. Date of Electronic Publication: 2010 Oct 04. - Publication Year :
- 2010
- Subjects :
- Cardiovascular Agents pharmacology
Carnitine O-Palmitoyltransferase antagonists & inhibitors
Energy Metabolism drug effects
Energy Metabolism physiology
Exercise Tolerance drug effects
Exercise Tolerance physiology
Humans
Myocardium metabolism
Perhexiline pharmacology
Cardiomyopathy, Hypertrophic drug therapy
Cardiomyopathy, Hypertrophic metabolism
Cardiovascular Agents therapeutic use
Perhexiline therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1524-4539
- Volume :
- 122
- Issue :
- 16
- Database :
- MEDLINE
- Journal :
- Circulation
- Publication Type :
- Editorial & Opinion
- Accession number :
- 20921436
- Full Text :
- https://doi.org/10.1161/CIRCULATIONAHA.110.981464